USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Business Analytics in Life Sciences
Business Analytics in Life Sciences
The Time is Ripe for a Technology Revamp in Clinical Trials
RELEASE DATE
24-Jun-2016
24-Jun-2016
REGION
Europe
Europe
Research Code: MC28-01-00-00-00
SKU: LS00267-EU-MR_18867
$3,000.00
In stock
SKU
LS00267-EU-MR_18867
Description
The drastic increase in the number of clinical trials performed worldwide is leading to a sharp rise in R&D expenditure incurred by life sciences companies. To overcome this challenge, companies are targeting clinical trials to achieve higher efficiencies, which will bring new drugs faster to market and reduce R&D cost burden. The solution lies in the technology revamp of future clinical trials, which is driven by implementation of effective business analytics solutions, the commoditization of hardware components, and the rise of Internet technologies offering big data analytics.
Table of Contents
Key Findings
Executive Summary
Current Challenges
Fallacies of Traditional Patient Recruitment Methods
EHR Data Use Cases are Expected to Evolve
EHR4CR Initiative in Europe Promotes Patient Data Usage in Trials
3 Backbones of a Successful Data-driven Approach to Clinical Trials
The UK is a Forerunner in Terms of Enabling Access to its National EHR Database for Clinical Research Purposes
Number of Clinical Studies has Increased Drastically—Only to Add Complexity and Costs
Trial Sponsors are Targeting Clinical Trials for Efficiency Gains
Key BA Applications for Clinical Trials
BA Solutions have Moved beyond KPI Dashboards
Evolution of Infrastructure Components and Data Repositories has Led to New BI Functionalities
Internet and Database Companies have Created New Repositories for Unstructured Data Management
BI Tools are Empowering Business and End Users
Advanced Analytics is not just Interactive Displays of Information
Future of Clinical Trials will Focus on Cost and Process Optimisation
Comparative Analysis of Key Vendors in BA for Life Sciences
Recommendations for Enterprises
Recommendations for Vendors
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition: Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Popular Topics
The drastic increase in the number of clinical trials performed worldwide is leading to a sharp rise in R&D expenditure incurred by life sciences companies. To overcome this challenge, companies are targeting clinical trials to achieve higher efficiencies, which will bring new drugs faster to market and reduce R&D cost burden. The solution lies in the technology revamp of future clinical trials, which is driven by implementation of effective business analytics solutions, the commoditization of hardware components, and the rise of Internet technologies offering big data analytics.
| No Index | No |
|---|---|
| Podcast | No |
| Author | Srikanth Venkataraman |
| WIP Number | MC28-01-00-00-00 |
| Is Prebook | No |